Human SUCLG1 activation kit by CRISPRa

CAT#: GA105848

SUCLG1 CRISPRa kit - CRISPR gene activation of human succinate-CoA ligase alpha subunit



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (3)
Rabbit Polyclonal antibody to SUCLG1 (succinate-CoA ligase, alpha subunit)
    • 100 ul

CNY 6,281.00


SUCLG1 (Myc-DDK-tagged)-Human succinate-CoA ligase, alpha subunit (SUCLG1), nuclear gene encoding mitochondrial protein
    • 10 ug

CNY 3,656.00
CNY 3,990.00


SUCLG1 Rabbit polyclonal Antibody
    • 100 ul

CNY 1,999.00
CNY 3,280.00

热销推荐

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol SUCLG1
Locus ID 8802
Kit Components

GA105848G1, SUCLG1 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA105848G2, SUCLG1 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA105848G3, SUCLG1 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_003849
Synonyms GALPHA; MTDPS9; SUCLA1
Summary This gene encodes the alpha subunit of the heterodimeric enzyme succinate coenzyme A ligase. This enzyme is targeted to the mitochondria and catalyzes the conversion of succinyl CoA and ADP or GDP to succinate and ATP or GTP. Mutations in this gene are the cause of the metabolic disorder fatal infantile lactic acidosis and mitochondrial DNA depletion. [provided by RefSeq, Feb 2010]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...